Atrium Biotechnologies, Inc.

Biotech company raises $75 million

Published in Pharma Investments, Ventures and Law Weekly, May 15th, 2005

AEterna Zentaris, Inc., (AEZ; AEZS) announced that its subsidiary, Atrium Biotechnologies, Inc., (ATB.sv), has successfully completed its initial public offering and secondary offering of 6,250,000 subordinate voting shares, issued at a price of $12 per share, for total proceeds of $75 million.

Atrium Biotechnologies' subordinate voting shares will trade on the Toronto Stock Exchange under the symbol "ATB.sv."

The 6,250,000 subordinate voting shares were sold to a syndicate of underwriters co-led by RBC Dominion Securities, Inc., and National Bank Financial, Inc., and including BMO Nesbitt Burns, Inc., CIBC World Markets, Inc., GMP Securities, Ltd.,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2005-05-15)

More Articles from Pharma Investments, Ventures and Law Weekly

Adventrx Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.04 per share
Akzo Nobel
Pharmaceutical firm publishes full-year 2004 figures under IFRS rules
Alnylam Pharmaceuticals, Inc.
Alliance formed for intellectual property for RNAi therapeutics
American Oriental Bioengineering, Inc.
Chinese pharmaceutical firm reports 53.2% increase in revenue
Andromed, Inc.
Diagnostics developer reports loss of $0.03 per share
Avanir Pharmaceuticals
Pharmaceutical firm completes $17.1M sale of common stock
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry